中文 | English
Return
Total: 58 , 1/6
Show Home Prev Next End page: GO
MeSH:(Lamivudine/pharmacology*)

1.Distribution of lamivudine- resistant variants in hepatitis B virus.

Guan-guan SU ; Dan-hong YANG ; Nian-feng ZHAO

Journal of Zhejiang University. Medical sciences 2003;32(4):349-358

2.Effects of lamivudine on growth of intestinal characteristic bacteria by microcalorimetry in vitro.

Cong-En ZHANG ; Jia-Yi WANG ; Jun-Jie HAO ; Dan YAN ; Rui-Lin WANG ; Rui-Sheng LI ; Jian-Yu LI ; Xiao-He XIAO

Acta Pharmaceutica Sinica 2013;48(10):1590-1594

3.In vitro evaluation on the effects of combined lamivudine (3TC) and Ara-AMP against hepatitis B virus.

Haibin SU ; Huifen WANG ; Wei JI ; Yanling ZHAO ; Guangming CAI

Chinese Journal of Experimental and Clinical Virology 2002;16(1):16-19

4.Efficacy and safety profiles of dolutegravir plus lamivudine vs . bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1.

Yinghua WEI ; Jin LI ; Ruhong XU ; Li WEN ; Yiming DENG ; Lixia HE ; Huijun ZHONG ; Yanhao WANG

Chinese Medical Journal 2023;136(22):2677-2685

5.Influence of SEN virus infection on their response to lamivudine in patients with chronic hepatitis B.

Dong XU ; De-Ying TIAN ; Zhen-gang ZHANG ; Hong-yun CHEN ; Pei-hui SONG

Chinese Journal of Hepatology 2003;11(11):683-685

6.Variants and quasispecies of reverse transcriptase region in polymerase gene of hepatitis B virus during lamivudine treatment.

Guo-bao TIAN ; Zheng ZENG ; Zhong-hong HUANG ; Hai-ying LU ; Min YU ; Wei-bo GONG ; Dong WANG ; Chong-wen SI

Chinese Journal of Experimental and Clinical Virology 2011;25(1):23-25

10.Construction of a duck hepatitis B virus YMDD mutant and identification of its resistance phenotype.

Xi-Hua FU ; Wei-Fang LIANG ; Xiao-Dong WU ; Guo-Jun SHEN ; Hai-Tang HE ; Jin-Jun CHEN ; Jin-Lin HOU

Journal of Southern Medical University 2011;31(4):633-636

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 58 , 1/6 Show Home Prev Next End page: GO